PCV11 EVALUATING CLINICAL OUTCOMES FOR SUBJECTS THAT ARE NEWLY INITIATED ON HMG-COA REDUCTASE INHIBITORS IN A NATURALISTIC ENVIRONMENT USING LONGITUDINAL DESIGN
May 1, 2004, 00:00
10.1016/S1098-3015(10)62377-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)62377-7/fulltext
Title :
PCV11 EVALUATING CLINICAL OUTCOMES FOR SUBJECTS THAT ARE NEWLY INITIATED ON HMG-COA REDUCTASE INHIBITORS IN A NATURALISTIC ENVIRONMENT USING LONGITUDINAL DESIGN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62377-7&doi=10.1016/S1098-3015(10)62377-7
First page :
Section Title :
Open access? :
No
Section Order :
315